Credit: UT Southwestern Medical Center
DALLAS - Jan. 13, 2021 - A new treatment that combines two existing medications may provide long-sought relief for many battling debilitating methamphetamine use disorder, according to a study to be published tomorrow in
The article, based on a multisite study funded by the National Institutes of Health (NIH), describes how combining an injectable drug currently used to treat alcohol and opioid addictions (naltrexone), and a commonly prescribed antidepressant (bupropion) produced positive results in 13.6 percent of the 403 patients treated, significantly higher than the 2.5 percent response in placebo groups. This is an important advance given that there are now no effective treatments for methamphetamine use disorder, says Madhukar Trivedi, M.D., a UT Southwestern professor of psychiatry and first author of the study.
Stroke survivors who had ceased to benefit from conventional rehabilitation gained clinically significant arm movement and control by using an external robotic device powered by their own brains, according to a study published in
Most patients retained the benefits for at least 2 months after the therapy sessions ended, suggesting the potential for long-lasting gains, Jose Luis Contreras-Vidal, director of the Non-Invasive Brain Machine Interface Systems Laboratory at the University of Houston, shares in a media release from the University of Houston.
Move on Demand
The trial involved training stroke survivors with limited movement in one arm to use a brain-machine interface (BMI), a computer program that captures brain activity to determine the subject’s intentions and then triggers an exoskeleton, or robotic device affixed to the affected arm, to move in response to those intentions. The device wouldn’t move if intention wasn’t detected, ensuring subjects remained engage
Stroke survivors who had ceased to benefit from conventional rehabilitation gained clinically significant arm movement and control by using an external robotic device powered by the patients' own brains.
Dr. Gregory A. Toback, Periodontist in New London, CT, Publishes Groundbreaking Research on Laser Dentistry
Share Article
Dr. Gregory A. Toback published groundbreaking research regarding the use of laser dentistry to treat the harmful effects of gum disease. With over 20 years of experience as a periodontist and extensive participation in revolutionary research and exclusive associations, Dr. Toback provides leading periodontal care, including advanced laser dentistry, in New London, CT and Westerly, RI.
Dr. Gregory A. Toback, New London, CT Periodontist, Publishes Groundbreaking Research
Dr. Toback provides advanced laser dentistry and revolutionary periodontal care in New London, CT and Westerly, RI.
Credit: KIRSTY CHALLEN, B.SC., MBCHB, MRES, PH.D., LANCASHIRE TEACHING HOSPITALS, UNITED KINGDOM.
DES PLAINES, IL Among children who were not in an independently verified incident, evaluation for child abuse should be done by specialty consultation in children aged less than three-years old presenting with rib fractures and children aged less than 18-months presenting with humeral or femoral fractures. That is the conclusion of a study titled Identifying Maltreatment in Infants and Young Children Presenting with Fractures: Does Age Matter?, to be published in the January 2021 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM).